Treatment of female sexual dysfunction

被引:12
|
作者
Ragucci, KR
Culhane, NS
机构
[1] Med Univ S Carolina, Dept Pharm Practice, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA
[3] Wilkes Univ, Nesbitt Sch Pharm, Dept Pharm Practice, Wilkes Barre, PA 18766 USA
关键词
estrogen; female sexual dysfunction; testosterone;
D O I
10.1345/aph.1C392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder. DATA SOURCES: Articles identified from a MEDLINE search (1 966-June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles. STUDY SELECTION AND DATA EXTRACTION: After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included. DATA SYNTHESIS: FSD is a multicausal and multidimensional problem combining biological, psychological, and interpersonal factors. The American Foundation for Urological Disease classifies FSD into 4 broad categories: sexual desire disorders, arousal disorder, orgasmic disorder, and sexual pain disorders. Depending on specific individual characteristics and category of disorder, a variety of potential treatments are available. Pharmacists can play a role in identifying and managing medication-related adverse effects that may be exacerbating FSD and educating women on treatment modalities. CONCLUSIONS: FSD is a complicated disorder that is often difficult to identify, classify, and treat appropriately. Pharmacists should have an understanding of the potential causes of FSD and the treatment options available so that they may make appropriate recommendations and counsel women effectively.
引用
收藏
页码:546 / 555
页数:10
相关论文
共 50 条
  • [31] Female sexual dysfunction
    Fitzhenry, D
    Sandberg, L
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) : 99 - 100
  • [32] Female sexual dysfunction
    Segraves, R. T.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S7 - S7
  • [33] Female sexual dysfunction
    不详
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (Suppl 7) : S22 - S26
  • [34] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2009, 36 (04) : 861 - +
  • [35] Female sexual dysfunction
    Armstrong, Duncan S.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (17) : 1312 - 1312
  • [36] Female sexual dysfunction
    Kershaw, Victoria
    Jha, Swati
    [J]. OBSTETRICIAN & GYNAECOLOGIST, 2022, 24 (01): : 12 - 23
  • [37] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2010, 33 (02) : 323 - +
  • [38] Female sexual dysfunction
    Jha, Swati
    Thakar, Ranee
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 153 (02) : 117 - 123
  • [39] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (04) : 681 - +
  • [40] Female sexual dysfunction
    Freedman, MA
    [J]. INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2002, 47 (01): : 18 - 21